Gaa na ọdịnaya

Laurie Glimcher

Shí Wikipedia, njikotá édémédé nke onyobulạ

 

Laurie Hollis Glimcher (amụrụ n'afọ 1951) bu dibia bekee-Sayensi na onye bu onye isi ala na onye isi oche nke Dana – Farber Cancer Institute.[1] A họpụtara ya ka ọ bụrụ onye otu American Philosophical Society na 2019. [citation need] Glimcher anọwo na etiti esemokwu metụtara ndị na-akwado ikike anụmanụ,[2] ịkwụ ụgwọ ụlọ ọrụ karịrị akarị,[3] na omume nyocha.[4] Nnyocha 2021 sitere n'aka ndị otu Boston Globe Spotlight gosipụtara ọrụ Glimcher na ọtụtụ bọọdụ ụlọ ọrụ, gụnyere Bristol Myers Squibb, GlaxoSmithKline, na Ngwaọrụ Analog.[5] Mgbe nyocha a gasịrị, Glimcher gara n'ihu na-anata ụgwọ ọrụ na bọọdụ ndị na-erite uru, ebe ọ na-agbakọ ụgwọ ọnwa ya ruo nde $ 4 kwa afọ na Dana-Farber.[6] N'October 2024, Glimcher gbara arụkwaghịm dị ka Onye isi ala na onye isi nke Dana-Farber Dana-Farber.[1] 

Agụmakwụkwọ

[dezie | dezie ebe o si]

Glimcher gụsịrị akwụkwọ na Winsor School, ụlọ akwụkwọ nzuzo ụmụ agbọghọ niile na Boston, Massachusetts, na 1968.[1] Na 1972, ọ gụsịrị akwụkwọ magna cum laude na Radcliffe College, wee gụchaa cum laude na Harvard Medical School n'afọ 1976[2]

Ọ sonyeere ndị isi ụlọ ọrụ Bristol-Myers Squibb na 1997 wee lara ezumike nka na bọọdụ na 2017.[1] [2] [3] Ụlọ nyocha nyocha ya nwetara ego n'aka Merck & Co maka oru ngo lekwasịrị anya na ịmepụta usoro ọgwụgwọ ọhụrụ maka ọgwụgwọ osteoporosis na 2008. [3]

Site na 2012 ruo 2016, Glimcher jere ozi dị ka Stephen na Suzanne Weiss Dean nke Weill Cornell Medical College na Cornell University Provost for Medical Affairs.[2][4]

Site na 2012 ruo 2016, Glimcher jere ozi dị ka Stephen na Suzanne Weiss Dean nke Weill Cornell Medical College na Cornell University Provost for Medical Affairs. [5] [6]

N'ọnwa Febụwarị 2016, akpọrọ Laurie Glimcher onye isi ala na onye isi oche nke Dana-Farber Cancer Institute. A tụlere Glimcher maka ọkwá maka Dean nke Harvard Medical School mana ọ tụgharịrị ọkwá ahụ ka ọ bụrụ onye isi oche nke Dana-Farber Cancer Institute.[7]

Na Dana-Farber, Glimcher jikọrọ aka na nyocha iji chọta ụzọ e si alụso ọrịa ọgụ ọgụ site n'ime usoro ahụ ji alụso ọrịa ọgụ mmadụ.[1] Dana-Farber Cancer Institute bụ ụlọ ọrụ jikọrọ Harvard, ebe ọ bụ ugbu a otu n'ime ụlọ ọgwụ nkuzi ya. Glimcher, onye bụ onye isi nwanyị mbụ nke ụlọ akwụkwọ ahụike ọ bụla na steeti New York, ghọrọ nwanyị mbụ na-eduzi ụlọ ọrụ Dana-Farber Cancer Institute.[8]

N'afọ 2017, ọ sonyeere bọọdụ GlaxoSmithKline . [9] N'afọ 2020, ọ sonyeere bọọdụ Analog Devices . [10]

Nchọpụta Glimcher lekwasịrị anya na usoro ahụ ji alụso ọrịa ọgụ; A maara ya maka ọrụ mbụ na T cell iche, nchọpụta ya na Schnurri-3 na-achịkwa osteoblasts nke mere ka ya na Merck & Co. na-emekọ ihe, na nchọpụta ya banyere ọrụ XBP-1 na-arụ na lipogenesis na nzaghachi protein na-apụta.[1][2]. Ọrụ Glimcher nyeere aka ịchọpụta Schnurri-3 (Shn3 maka nkenke) bụ nnukwu protein mkpịsị aka zinc nwere njikọ na Drosophila. Shn bụ onye na-ahụ maka nhazi ọkpụkpụ nke okenye.[3] Nnyocha ya enwewo mmetụta maka ịghọta ụkwara ume ọkụ, HIV, ọrịa bowel inflammatory, na osteoporosis, na gburugburu 2016, na ọrịa cancer immunotherapy.[11]

Ihe nrite na ndị otu

[dezie | dezie ebe o si]

Arụmụka NYBC

[dezie | dezie ebe o si]

Arụmụka banyere njikwa data

[dezie | dezie ebe o si]

Na Jenụwarị 2024 Glimcher so na ndị nyocha anọ na Dana-Farber ebubo ụgha data na akwụkwọ nyocha. Ejirila foto ndị dị n'akwụkwọ akụkọ ahụ mee ihe n'ụzọ tụrụ aro ka a kpachaara anya na-agba mbọ iduhie ndị na-agụ akwụkwọ.[1] Ọ nwara imezi ụfọdụ n'ime data ahụ, agbanyeghị, eweghachila isii n'ime akwụkwọ ndị a ka a na-emezi nyocha ebe ndị ọzọ na-agbazi.[12][13]

  • Ụlọ Ọrụ Na-ahụ Maka Ọrịa Cancer Dana-Farber
  • Omume ọjọọ sayensị

Edensibịa

[dezie | dezie ebe o si]
  1. Edelman (2024-09-03). Dana-Farber CEO Laurie Glimcher to step down next month. BostonGlobe.com. Retrieved on 2024-10-12.
  2. 1 2 Laurie H. Glimcher, MD - Dana–Farber Cancer Institute | Boston, MA. www.dana-farber.org. Retrieved on 2020-03-26."Laurie H. Glimcher, MD - Dana–Farber Cancer Institute | Boston, MA". www.dana-farber.org. Retrieved 2020-03-26.
  3. "Harvard Announces Pioneering Collaboration with Merck & Co., Inc. to Advance Osteoporosis Research". Retrieved on October 16, 2017.
  4. Hartocollis, Anemona. "Harvard Researcher Chosen as New Dean of Weill Cornell Medical College", The New York Times, September 7, 2011. Retrieved on September 9, 2011.
  5. Bristol-Myers Squibb: Laurie H. Glimcher, M.D.. www.bms.com. Retrieved on 2016-12-08.
  6. Hartocollis. "Laurie H. Glimcher Named Dean of Weill Cornell Medical College", The New York Times, 2011-09-07. Retrieved on 2016-10-11.
  7. Recruited to lead Harvard med, 'fearless' scientist chose Dana-Farber. STAT (2016-03-01). Retrieved on 2016-12-08.
  8. Laurie Glimcher (en-us). The Forum at Harvard T. H. Chan School of Public Health (2019-01-17). Retrieved on 2020-11-03.
  9. Cancer expert joins the overhaul at Glaxo - The Times (en-US). The Times (July 22, 2017). Retrieved on 2021-07-21.
  10. Dana-Farber CEO joining Analog board - The Boston Globe. BostonGlobe.com (August 18, 2020). Retrieved on 2020-11-17.
  11. Recruited to lead Harvard med, 'fearless' scientist chose Dana-Farber. STAT (2016-03-01). Retrieved on 2016-10-11.
  12. Paulus. "Dana‑Farber Cancer Institute Researchers Accused of Manipulating Data", The Harvard Crimson, January 12, 2024. Retrieved on 2024-01-23.
  13. Paulus. "Dana‑Farber Cancer Institute Issues Corrections to Research Records", The Harvard Crimson, January 22, 2024. Retrieved on 2024-01-23.